Andy Hurwitz

Andy is Repertoire’s Head of Immunology, which includes the company’s Discovery Immunology and Applied Immunology groups.

Andy joined Repertoire from Mana Therapeutics, where he was SVP, Head of Research. In his role at Mana, he instrumental in the company’s development into an operational R&D organization. Prior to joining Mana, Andy was VP, Head of Preclinical Research at AgenTus Therapeutics (now MiNK Therapeutics). His group was responsible for progressing a T cell receptor (TCR) candidate from discovery to development and another TCR candidate from the discovery stage to Investigational New Drug (IND)-enabling studies. Before joining AgenTus, Andy was a Principal Investigator at the National Institutes of Health (NIH) for over a decade.

Andy received his B.S. in Biology and French from Tufts University and his PhD in Pathology from the Albert Einstein College of Medicine.